Crossmark

Drug treatment of heart failure in the elderly

Crossref DOI link: https://doi.org/10.1007/s00059-017-4668-9

Published Online: 2018-01-16

Published Print: 2018-05

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Berliner, D.

Bauersachs, J.
License Information

Text and Data Mining valid from 2018-01-16
More Information

Article History

First Online: 16 January 2018

Compliance with ethical guidelines

:

: D. Berliner: honoraria/advisory board/travel support: Novartis, Abbott, Daiichi Sankyo, Bayer, Boehringer Ingelheim. J. Bauersachs: honoraria and consultancy fees from Novartis, Pfizer, Vifor, Bayer, Servier; grants from Bayer and Vifor.

: This article does not contain any studies with human participants or animals performed by any of the authors.